Piper Sandler has downgraded Zimmer Biomet (NYSE:ZBH) to neutral, citing a lack of near-term catalysts. The investment bank said it sees “limited” upside to large joint estimates for the second half ...
Source LinkPiper Sandler has downgraded Zimmer Biomet (NYSE:ZBH) to neutral, citing a lack of near-term catalysts. The investment bank said it sees “limited” upside to large joint estimates for the second half ...
Source Link
Comments